Tristel plc (LON:TSTL – Get Free Report) announced a dividend on Monday, October 21st,Upcoming Dividends.Co.Uk reports. Stockholders of record on Thursday, November 28th will be paid a dividend of GBX 8.28 ($0.10) per share on Friday, December 20th. This represents a dividend yield of 2.1%. The ex-dividend date is Thursday, November 28th. This is a positive change from Tristel’s previous dividend of $5.24. The official announcement can be accessed at this link.
Tristel Trading Up 0.6 %
LON TSTL opened at GBX 442.50 ($5.56) on Wednesday. The firm has a market capitalization of £210.85 million, a price-to-earnings ratio of 3,353.85 and a beta of 0.23. The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92. Tristel has a one year low of GBX 346 ($4.35) and a one year high of GBX 572.50 ($7.20). The company’s 50 day moving average price is GBX 404.18 and its 200 day moving average price is GBX 437.31.
Insider Transactions at Tristel
In related news, insider Elizabeth Dixon sold 50,000 shares of the firm’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of GBX 397 ($4.99), for a total transaction of £198,500 ($249,528.60). Company insiders own 4.89% of the company’s stock.
About Tristel
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Further Reading
- Five stocks we like better than Tristel
- What is an Earnings Surprise?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stock Market Upgrades: What Are They?
- 2 Generic Drug Stocks Ready to Surge in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Receive News & Ratings for Tristel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel and related companies with MarketBeat.com's FREE daily email newsletter.